Skip to main content
. Author manuscript; available in PMC: 2024 May 12.
Published in final edited form as: Psychopharmacology (Berl). 2023 May 2;240(6):1373–1386. doi: 10.1007/s00213-023-06376-w

Fig. 5.

Fig. 5

Repeated liraglutide administration prevented nicotine withdrawal-induced hyperphagia and body weight gain in female rats. (A) Repeated liraglutide administration attenuated daily HFD intake during nicotine abstinence (n=9 saline/vehicle, 6 saline/liraglutide, 8 nicotine/vehicle, 11 nicotine/liraglutide: *p<0.05 vs saline/ vehicle, ^p<0.05 vs nicotine/vehicle, Tukey’s). (B) Repeated liraglutide administration decreased cumulative HFD intake during nicotine abstinence in nicotine-experienced female rats (*p<0.01, **p<0.0001, Tukey’s). (C) Repeated liraglutide administration prevented body weight gain during withdrawal in nicotine-experienced female rats (*p<0.05, Tukey’s). There were no effects of repeated liraglutide on daily water intake (D) and kaolin intake (E) during nicotine withdrawal in female rats.